Irwin M E, Gulamhusein S S, Senaratne M P, St Clair W R
Division of Cardiology, Grey Nuns Hospital, Edmonton, Alberta, Canada.
Pacing Clin Electrophysiol. 1994 Nov;17(11 Pt 2):2027-31. doi: 10.1111/j.1540-8159.1994.tb03794.x.
The purpose of this review was to evaluate the economical benefits and outcomes of an ambulatory pacing system implantation program that began in 1991 for new and replacement pacing system implantations. Patient access, incidence of complications, hospital bed day utilization, economic impact, safety, and practicality of the Ambulatory Pacing System Implantation Program was retrospectively reviewed from August 1991 to March 1994. The Ambulatory Pacing System Implantation Program includes pre-operative outpatient assessment in the pacemaker clinic, admission to the Day Medical Unit followed by same day pacing system implantation, discharge home after a short period of observation, and, in selected cases, cardiac monitoring, followed by pacemaker clinic visit 24-hours postimplantation.
Two hundred four cardiac pacing systems, 154 new and 50 replacements (pulse generator/leads), were implanted under the guidelines of the Ambulatory Pacing System Implantation Program between August 1991 and March 1994. Eighty-seven percent of the patients were implanted with passive fixation leads, the remaining with active fixation leads; all but four of which were leads implanted in the atria. Preprocedure wait time was decreased from 16 to 2 days for elective pacing system implantation. The incidence of lead dislodgment in the first, second, and third year of the Ambulatory Pacing System Implantation Program was 20%, 12%, 5%, respectively; compared to 11% for a similar number of cases in previous years done as inpatients. The incidence of new infection was 2.4% compared to < 1% in previous years. Six of the 204 (2%) cases required admission overnight. A total savings of 1,456 bed days ($1,275,450.00; Canadian) has been realized for an equivalent number of cases when compared with previous years. The operational cost was reduced by $3,976.00 per case.
It has been shown that the Ambulatory Pacing System Implantation Program has improved client access, and is a safe and economical approach to implantation of cardiac pacing systems.
本综述的目的是评估1991年开始的门诊起搏系统植入计划在新的和更换起搏系统植入方面的经济效益和结果。回顾性分析了1991年8月至1994年3月期间门诊起搏系统植入计划的患者准入情况、并发症发生率、医院病床日利用率、经济影响、安全性和实用性。门诊起搏系统植入计划包括在起搏器门诊进行术前门诊评估,入住日间医疗单元,随后当天进行起搏系统植入,经过短时间观察后出院回家,在某些情况下进行心脏监测,植入后24小时到起搏器门诊就诊。
1991年8月至1994年3月期间,在门诊起搏系统植入计划的指导下,共植入了204个心脏起搏系统,其中154个为新植入,50个为更换(脉冲发生器/导线)。87%的患者植入了被动固定导线,其余植入了主动固定导线;除4根外,其余均为心房植入导线。择期起搏系统植入的术前等待时间从16天缩短至2天。门诊起搏系统植入计划第一年、第二年和第三年的导线脱位发生率分别为20%、12%、5%;相比之下,前几年类似数量的住院病例发生率为11%。新感染发生率为2.4%,而前几年<1%。204例(2%)病例中有6例需要过夜住院。与前几年相比,同等数量的病例总共节省了1456个病床日(1275450.00加元)。每例手术成本降低了3976.00加元。
已表明门诊起搏系统植入计划改善了患者准入,是一种安全且经济的心脏起搏系统植入方法。